Kevin Schug, an associate professor of chemistry and biochemistry at The University of Texas (UT) at Arlington, has been named the university's new Shimadzu Distinguished Professor of Analytical Chemistry.
Kevin Schug, an associate professor of chemistry and biochemistry at The University of Texas (UT) at Arlington, has been named the university’s new Shimadzu Distinguished Professor of Analytical Chemistry. He will also oversee a new Shimadzu Center for Advanced Analytical Chemistry, which has been established through an in-kind gift valued at nearly $3 million from Shimadzu Scientific Instruments (Columbia, Maryland).
Schug said the facility will provide many new capabilities that were not previously available. These, include enhanced capabilities for matrix-assisted laser desorption–ionization (MALDI), including ion trap–time-of-flight (IT–TOF), TOF-TOF, and high mass systems; proteomics and bioinformatics capabilities for use following liquid chromatography–mass spectrometry (LC–MS) and MALDI –MS analysis; polymer characterization by gel-permeation chromatography–MALDI with automated fractionation and spotting; MS surface imaging with chemical inkjet printer technology; and comprehensive metals analysis by inductively coupled plasma–optical emission spectroscopy (ICP–OES).
“In general, we have built a facility that can handle virtually any molecular analysis scenario,” said Schug.
Schug also noted that the central location of the Shimadzu Center would allow researchers in the UT College of Science and the College of Engineering to access the enhanced capabilities for trace qualitative and quantitative analysis. The facility also will be available for use by area businesses on a contract basis.
“UT Arlington has a dynamic science program focused on the future, and Shimadzu is pleased and eager to support such a research institution,” said Shuzo Maruyama, president of Shimadzu Scientific Instruments. “Kevin Schug is one of the leading young scientists in the country, and it will be a pleasure to work with him and the entire team at UT Arlington on future projects.”
The instruments, which are now up and running, will be used for research into the prevention and treatment of illnesses such as cancer and malaria, as well as in the development of nanofabrication materials for industry. Examples of some of the cutting-edge research that will be aided by the instruments available in the new center include:
• Research led by Schug using MALDI-TOF MS equipment to analyze cuticular lipids that can reveal age in a species of mosquito known for spreading malaria. Effective methods for analyzing mosquito age could help biochemical-based efforts to prevent spread of the disease, since younger mosquitoes are non-contagious. Schug will also use new metals analysis equipment in an ongoing study of private well water samples collected near natural gas sites.
• Subhrangsu Mandal, associate professor of chemistry and biochemistry, is currently looking for chemicals in the environment that could interfere with normal hormone functions and, possibly, fuel cancer growth. The MS equipment will help him better analyze test items such as commonly used growth hormones, water from various sources and milk. He received a 2010 grant of nearly $500,000 from the National Institutes of Health to fund his work.
• Jian Yang, associate professor of bioengineering, will use the new high performance liquid chromatography (HPLC) and MS equipment in his work on biodegradable fluorescent polymers. These polymers can help deliver chemotherapeutic agents to cancers and also enable sensitive cancer detection through optical imaging. Yang recently received a $1.25 million National Institutes of Health grant for this work.
Schug won the 2010 Eli Lilly Young Analytical Scientist Award, which recognizes a researcher doing work relevant to the pharmaceutical industry. He also is a member of the LCGC North America Editorial Advisory Board.
Measuring Stress and Reproductive Hormones in Dolphins with UPLC
November 25th 2024A recent study measured stress and reproductive hormones in three stocks of free-ranging bottlenose dolphins inhabiting different natural salinities across the Gulf of Mexico, with hormones extracted from the blubber of 82 remotely biopsied dolphins and quantified using ultra performance liquid chromatography (UPLC) coupled with orbitrap fusion mass spectrometry.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.